NCT01355341

Safety and Efficacy of Herbmed Plus in Patients withRenal Calculi

A Phase II, 28 Week, Randomized, Double- Blind, Placebo- Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of 'Herbmed Plus' an Ayurvedic Formulation in Patients With Renal Calculi

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 84 (estimated)
• Sponsor: Amai Charitable Trust · Academic / Other
• Sex: All
• Age: 10 Years – 75 Years
• Healthy volunteers: Accepted

Summary

More specifically, the present invention relates to a 'Herbal Preparation' that is useful for * Treatment of Renal calculi * Reduction in the stone size \& surface area * The expulsion of stone * Decreased need of Analgesic(Antiinflammatory Effect) * Stops the recurrence and reformation of renal

Detailed description

1. Study duration 28 weeks 2. No. of Scheduled visits 8 visits 3. Study product Dose, Group one-:1capsule (of 500 mg) orally twice a day with meals for 24 weeks. Group two-:placebo1capsule (of 500 mg) orally twice a day with meals for 24 weeks.

Conditions

• RENAL CALCULI

Interventions

Type	Name	Description
DRUG	HERBMED PLUS	500 mg Twice day for 6 month with lunch and dinner.

Timeline

• Start date: 2010-04-01
• Primary completion: 2011-12-01
• Completion: 2011-12-01
• First posted: 2011-05-18
• Last updated: 2011-05-18

Locations

1 site across 1 country: India